炎症性肠病组织病理学评估与报告:Haggitt胃肠病理学会共识文件
该共识由Rodger C. Haggitt胃肠病理学会发起,针对疑似或确诊炎症性肠病(IBD)患者标本,提出初始诊断、监测期活动度评估和术后长期预后三个阶段的宏观与组织学检查建议,共20条主要立场声明,经全体作者及外部病理学家和消化科医生评审投票批准。
要点
- IBD病理报告应规范术语和必要元素,分初始诊断、监测活动度、术后预后三个层次。
- 共识包含20条主要立场声明,每条附文献回顾,部分有补充声明。
- IBD相关肿瘤将在另一份后续文件中单独讨论。
核心结论
- 该共识为IBD标本的宏观和组织学评估及报告提供了分三个疾病演变阶段的规范化建议,共20条主要立场声明。
研究设计与样本
- 由Rodger C. Haggitt胃肠病理学会发起并赞助的共识文件,基于调查显示多数受访者认为IBD报告指南将影响其日常实践。
主要发现
- 共识针对疑似或确诊IBD患者的标本,在初始诊断(内镜活检)、结肠镜监测期间疾病活动度评估和手术后长期预后评估三个不同阶段提出建议。
关键数值与推荐
- 共提出20条主要立场声明,每条附简要文献回顾,部分有补充声明,反映现有已发表证据的强度。
- 声明经所有作者以及一组在IBD诊疗方面有明确兴趣和经验的病理学家和消化科医生评审、投票和批准。
临床怎么用
- 病理医生可依据该共识对IBD标本进行规范化宏观和组织学评估及报告,分初始诊断、监测活动度和术后预后三个层次。
局限性
- IBD相关肿瘤未在本文件中讨论,将在另一份后续文件中单独考虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The histopathologic evaluation and diagnosis of specimens from patients with inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn disease, is complicated, yet clinically important. Therefore, formalized recommendations about appropriate terminology and necessary elements to include in the corresponding report are likely to benefit practicing pathologists. This consensus document was initiated and sponsored by the Rodger C. Haggitt Gastrointestinal Pathology Society after the majority of respondents in a survey indicated that IBD reporting guidelines would inform their daily practice. The document presented herein provides recommendations for the macroscopic and histologic examination of samples from patients with suspected or confirmed IBD at 3 distinct tiers of disease evolution: initial diagnosis with endoscopic biopsies, assessment of disease activity during colonoscopic surveillance, and evaluation of long-term prognosis after surgery. Given its complexity and importance, IBD-related neoplasia will be considered in a separate, forthcoming document. These recommendations, presented as 20 main position statements, each following a brief review of the pertinent literature and some with additional supplemental statements, reflect the strength of available published evidence. They were subjected to review, voting, and approval by all authors and, in addition, by a group of surgical pathologists and gastroenterologists with documented interest and experience in the diagnosis and treatment of patients with IBD. We hope this document is the first in a dynamic series with subsequent iterations and revisions incorporating emerging data and evolving approaches to management.
引用
- Polydorides AD, Liu X, Hu S, et al. Histopathologic Evaluation and Reporting in Inflammatory Bowel Disease: A Consensus Document Sponsored by the Rodger C. Haggitt Gastrointestinal Pathology Society. Mod Pathol. 2026. PMID: 41985626. doi:10.1016/j.modpat.2026.101002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。